These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 26580592)
1. Berberine Sulfate Attenuates Osteoclast Differentiation through RANKL Induced NF-κB and NFAT Pathways. Zhou L; Song F; Liu Q; Yang M; Zhao J; Tan R; Xu J; Zhang G; Quinn JM; Tickner J; Xu J Int J Mol Sci; 2015 Nov; 16(11):27087-96. PubMed ID: 26580592 [TBL] [Abstract][Full Text] [Related]
2. Bajijiasu Abrogates Osteoclast Differentiation via the Suppression of RANKL Signaling Pathways through NF-κB and NFAT. Hong G; Zhou L; Shi X; He W; Wang H; Wei Q; Chen P; Qi L; Tickner J; Lin L; Xu J Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106828 [TBL] [Abstract][Full Text] [Related]
3. Protein kinase C inhibitor, GF109203X attenuates osteoclastogenesis, bone resorption and RANKL-induced NF-κB and NFAT activity. Yao J; Li J; Zhou L; Cheng J; Chim SM; Zhang G; Quinn JM; Tickner J; Zhao J; Xu J J Cell Physiol; 2015 Jun; 230(6):1235-42. PubMed ID: 25363829 [TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E inhibits osteoclast differentiation via regulation of c-Fos, NFATc1 and NF-κB. Kim WS; Kim HJ; Lee ZH; Lee Y; Kim HH Exp Cell Res; 2013 Feb; 319(4):436-46. PubMed ID: 23246654 [TBL] [Abstract][Full Text] [Related]
5. Caffeic acid phenethyl ester, an active component of honeybee propolis attenuates osteoclastogenesis and bone resorption via the suppression of RANKL-induced NF-kappaB and NFAT activity. Ang ES; Pavlos NJ; Chai LY; Qi M; Cheng TS; Steer JH; Joyce DA; Zheng MH; Xu J J Cell Physiol; 2009 Dec; 221(3):642-9. PubMed ID: 19681045 [TBL] [Abstract][Full Text] [Related]
6. Berberine Suppresses RANKL-Induced Osteoclast Differentiation by Inhibiting c-Fos and NFATc1 Expression. Han SY; Kim YK Am J Chin Med; 2019; 47(2):439-455. PubMed ID: 30827151 [TBL] [Abstract][Full Text] [Related]
7. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways. Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253 [TBL] [Abstract][Full Text] [Related]
8. Ginsenoside Rb2 inhibits osteoclast differentiation through nuclear factor-kappaB and signal transducer and activator of transcription protein 3 signaling pathway. Cong F; Liu J; Wang C; Yuan Z; Bi L; Liang J; Su K; Qiu Y; Song T; Fan J; Chao G Biomed Pharmacother; 2017 Aug; 92():927-934. PubMed ID: 28605877 [TBL] [Abstract][Full Text] [Related]
9. Novel antiosteoclastogenic activity of phloretin antagonizing RANKL-induced osteoclast differentiation of murine macrophages. Kim JL; Kang MK; Gong JH; Park SH; Han SY; Kang YH Mol Nutr Food Res; 2012 Aug; 56(8):1223-33. PubMed ID: 22700286 [TBL] [Abstract][Full Text] [Related]
10. Eriodictyol Inhibits RANKL-Induced Osteoclast Formation and Function Via Inhibition of NFATc1 Activity. Song F; Zhou L; Zhao J; Liu Q; Yang M; Tan R; Xu J; Zhang G; Quinn JM; Tickner J; Huang Y; Xu J J Cell Physiol; 2016 Sep; 231(9):1983-93. PubMed ID: 26754483 [TBL] [Abstract][Full Text] [Related]
11. Aconine inhibits RANKL-induced osteoclast differentiation in RAW264.7 cells by suppressing NF-κB and NFATc1 activation and DC-STAMP expression. Zeng XZ; He LG; Wang S; Wang K; Zhang YY; Tao L; Li XJ; Liu SW Acta Pharmacol Sin; 2016 Feb; 37(2):255-63. PubMed ID: 26592521 [TBL] [Abstract][Full Text] [Related]
12. Sophorae Flos extract inhibits RANKL-induced osteoclast differentiation by suppressing the NF-κB/NFATc1 pathway in mouse bone marrow cells. Kim JM; Lee JH; Lee GS; Noh EM; Song HK; Gu DR; Kim SC; Lee SH; Kwon KB; Lee YR BMC Complement Altern Med; 2017 Mar; 17(1):164. PubMed ID: 28335757 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of receptor activator of nuclear factor-κB ligand- or lipopolysaccharide-induced osteoclast formation by conophylline through downregulation of CREB. Koide N; Kondo Y; Odkhuu E; Ulziisaikhan J; Ukaji T; Yokochi T; Umezawa K Immunol Lett; 2014 Sep; 161(1):31-7. PubMed ID: 24792671 [TBL] [Abstract][Full Text] [Related]
14. Neohesperidin suppresses osteoclast differentiation, bone resorption and ovariectomised-induced osteoporosis in mice. Tan Z; Cheng J; Liu Q; Zhou L; Kenny J; Wang T; Lin X; Yuan J; Quinn JMW; Tickner J; Hong G; Qin A; Zhao J; Xu J Mol Cell Endocrinol; 2017 Jan; 439():369-378. PubMed ID: 27664516 [TBL] [Abstract][Full Text] [Related]
15. Hispidulin attenuates bone resorption and osteoclastogenesis via the RANKL-induced NF-κB and NFATc1 pathways. Nepal M; Choi HJ; Choi BY; Yang MS; Chae JI; Li L; Soh Y Eur J Pharmacol; 2013 Sep; 715(1-3):96-104. PubMed ID: 23791609 [TBL] [Abstract][Full Text] [Related]
16. Osthole inhibits osteoclasts formation and bone resorption by regulating NF-κB signaling and NFATc1 activations stimulated by RANKL. Ma Y; Wang L; Zheng S; Xu J; Pan Y; Tu P; Sun J; Guo Y J Cell Biochem; 2019 Sep; 120(9):16052-16061. PubMed ID: 31081953 [TBL] [Abstract][Full Text] [Related]
17. Coptisine inhibits RANKL-induced NF-κB phosphorylation in osteoclast precursors and suppresses function through the regulation of RANKL and OPG gene expression in osteoblastic cells. Lee JW; Iwahashi A; Hasegawa S; Yonezawa T; Jeon WB; Cha BY; Nagai K; Woo JT J Nat Med; 2012 Jan; 66(1):8-16. PubMed ID: 21656335 [TBL] [Abstract][Full Text] [Related]
18. Yukmijihwang-tang inhibits receptor activator for nuclear Factor-κB ligand-induced osteoclast differentiation. Shim KS; Ma CJ; Kim DS; Ma JY J Med Food; 2011 Nov; 14(11):1439-47. PubMed ID: 21883017 [TBL] [Abstract][Full Text] [Related]
19. Poligoni Multiflori Radix enhances osteoblast formation and reduces osteoclast differentiation. Han SY; Lee KH; Kim YK Int J Mol Med; 2018 Jul; 42(1):331-345. PubMed ID: 29620250 [TBL] [Abstract][Full Text] [Related]
20. Ginsenoside Rh2 inhibits osteoclastogenesis through down-regulation of NF-κB, NFATc1 and c-Fos. He L; Lee J; Jang JH; Lee SH; Nan MH; Oh BC; Lee SG; Kim HH; Soung NK; Ahn JS; Kim BY Bone; 2012 Jun; 50(6):1207-13. PubMed ID: 22484180 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]